ArticleJournal of experimental & clinical cancer research : CR2025

Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade.

Chao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.